Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.

<h4>Background</h4>Increasing evidences indicate that systemic inflammation plays a significant role of adverse prognosis in patients with coronary heart disease (CHD). The inflammatory burden index (IBI) is a novel biomarker that reflects systemic inflammation. The aim of this study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen Lu, Xiaoqin Liao, Yan Jiang, Baolin Luo, Liangwan Chen, Yanjuan Lin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0325287
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849427504760094720
author Wen Lu
Xiaoqin Liao
Yan Jiang
Baolin Luo
Liangwan Chen
Yanjuan Lin
author_facet Wen Lu
Xiaoqin Liao
Yan Jiang
Baolin Luo
Liangwan Chen
Yanjuan Lin
author_sort Wen Lu
collection DOAJ
description <h4>Background</h4>Increasing evidences indicate that systemic inflammation plays a significant role of adverse prognosis in patients with coronary heart disease (CHD). The inflammatory burden index (IBI) is a novel biomarker that reflects systemic inflammation. The aim of this study was to investigate the association between IBI and prognosis of CHD patients.<h4>Methods</h4>In this retrospective analysis, data from 2453 CHD patients enrolled from December 2017 to December 2022.IBI was defined as neutrophil/lymphocyte*C-reactive protein, with patients categorized into four groups based on quartiles of baseline IBI levels. The primary outcome was adverse cardiovascular and cerebrovascular events (MACCEs) occurring during hospitalization, which included repeat revascularization, new-onset atrial fibrillation (NOAF), stroke, and all-cause in-hospital mortality. Multivariate logistic regression models and restricted cubic spline (RCS) analysis were used to investigate the association between IBI and prognosis of CHD patients.<h4>Results</h4>High levels of IBI were associated with higher risk of MACCEs, especially when IBI ≥ 45.68, patients exhibited a higher risk of MACCEs (P < 0.05). After adjusting for baseline confounders, multivariate logistic regression analysis demonstrated that baseline IBI was an independent predictor for NOAF (Odds Ratio (OR): 2.05; 95% confidence interval (CI): 1.30-3.24; P = 0.002) and contrast-induced nephropathy (CIN) (OR: 1.95; 95%CI: 1.16-3.28; P = 0.012) in CHD patients, mainly driven by the highest quartile. In addition, RCS confirmed a linear relationship between IBI and NOAF (P for non-linear = 0.425) and a nonlinear relationship with CIN (P for non-linear = 0.032).<h4>Conclusion</h4>IBI is a promising biomarker of systemic inflammation in CHD patients, where higher IBI levels are associated with adverse prognosis. These findings may aid clinicians in precise decision-making to improve outcomes in patients with CHD.
format Article
id doaj-art-6e29beec864d4a8d9f2dfb41125e95b4
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-6e29beec864d4a8d9f2dfb41125e95b42025-08-20T03:29:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032528710.1371/journal.pone.0325287Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.Wen LuXiaoqin LiaoYan JiangBaolin LuoLiangwan ChenYanjuan Lin<h4>Background</h4>Increasing evidences indicate that systemic inflammation plays a significant role of adverse prognosis in patients with coronary heart disease (CHD). The inflammatory burden index (IBI) is a novel biomarker that reflects systemic inflammation. The aim of this study was to investigate the association between IBI and prognosis of CHD patients.<h4>Methods</h4>In this retrospective analysis, data from 2453 CHD patients enrolled from December 2017 to December 2022.IBI was defined as neutrophil/lymphocyte*C-reactive protein, with patients categorized into four groups based on quartiles of baseline IBI levels. The primary outcome was adverse cardiovascular and cerebrovascular events (MACCEs) occurring during hospitalization, which included repeat revascularization, new-onset atrial fibrillation (NOAF), stroke, and all-cause in-hospital mortality. Multivariate logistic regression models and restricted cubic spline (RCS) analysis were used to investigate the association between IBI and prognosis of CHD patients.<h4>Results</h4>High levels of IBI were associated with higher risk of MACCEs, especially when IBI ≥ 45.68, patients exhibited a higher risk of MACCEs (P < 0.05). After adjusting for baseline confounders, multivariate logistic regression analysis demonstrated that baseline IBI was an independent predictor for NOAF (Odds Ratio (OR): 2.05; 95% confidence interval (CI): 1.30-3.24; P = 0.002) and contrast-induced nephropathy (CIN) (OR: 1.95; 95%CI: 1.16-3.28; P = 0.012) in CHD patients, mainly driven by the highest quartile. In addition, RCS confirmed a linear relationship between IBI and NOAF (P for non-linear = 0.425) and a nonlinear relationship with CIN (P for non-linear = 0.032).<h4>Conclusion</h4>IBI is a promising biomarker of systemic inflammation in CHD patients, where higher IBI levels are associated with adverse prognosis. These findings may aid clinicians in precise decision-making to improve outcomes in patients with CHD.https://doi.org/10.1371/journal.pone.0325287
spellingShingle Wen Lu
Xiaoqin Liao
Yan Jiang
Baolin Luo
Liangwan Chen
Yanjuan Lin
Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.
PLoS ONE
title Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.
title_full Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.
title_fullStr Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.
title_full_unstemmed Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.
title_short Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study.
title_sort association between inflammatory burden index and prognosis in patients with coronary heart disease a retrospective study
url https://doi.org/10.1371/journal.pone.0325287
work_keys_str_mv AT wenlu associationbetweeninflammatoryburdenindexandprognosisinpatientswithcoronaryheartdiseasearetrospectivestudy
AT xiaoqinliao associationbetweeninflammatoryburdenindexandprognosisinpatientswithcoronaryheartdiseasearetrospectivestudy
AT yanjiang associationbetweeninflammatoryburdenindexandprognosisinpatientswithcoronaryheartdiseasearetrospectivestudy
AT baolinluo associationbetweeninflammatoryburdenindexandprognosisinpatientswithcoronaryheartdiseasearetrospectivestudy
AT liangwanchen associationbetweeninflammatoryburdenindexandprognosisinpatientswithcoronaryheartdiseasearetrospectivestudy
AT yanjuanlin associationbetweeninflammatoryburdenindexandprognosisinpatientswithcoronaryheartdiseasearetrospectivestudy